Corticosteroids in polymyalgia rheumatica - A review of different treatment schedules

C. Li, B. Dasgupta

Department of Rheumatology, Southend Hospital, Prittlewell Chase, Westcliff-on-Sea, Essex, UK.

ABSTRACT
Low dose oral steroids (prednisolone 10-15 mg daily) are currently advocated for the treatment of uncomplicated PMR and the dose should be carefully adjusted in relation to disease activity. Intramuscular methylprednisolone has been shown to have a similar remission rate to oral steroids and a better side effect profile with respect to fracture rate and weight gain. Prophylaxis for osteoporosis at least with calcium and vitamin D should be initiated at the start of steroid therapy.

Key words
Polymyalgia rheumatica, treatment.

Please address correspondence and reprint requests to: Bhaskar Dasgupta, MD, Department of Rheumatology, Southend General Hospital, Wescliff-on-sea, Essex SS0 ORY, UK.
E-mail: dr.dasgupta@southend-hospital.thenhs.com

Clin Exp Rheumatol 2000; 18 (Suppl. 20): S56-S57.
© Copyright Clinical and Experimental Rheumatology 2000.